TABLE 5.
Antimicrobial resistance patterns for Shigella isolates from patients with available travel information* (1997 to 2000)
| Year | Isolate | Resistance pattern | Travel destination(s) |
|---|---|---|---|
| 1997 | Shigella sonnei | AmPiT/S | Romania |
| 1997 | Shigella flexneri | AmT/S | El Salvador |
| 1997 | Shigella flexneri | Am | Russia |
| 1997 | Shigella flexneri | T/S | Nepal |
| 1997 | Shigella dysenteriae | Susceptible | Madagascar |
| 1998 | Shigella sonnei | Susceptible | Dominican Republic |
| 1998 | Shigella flexneri | AmAugCPiTeT/S | Nicaragua |
| 1998 | Shigella flexneri | AmAugCTe | Ethiopia |
| 1998 | Shigella boydii | AmAugCaxTeT/S | India |
| 1998 | Shigella boydii | AmAugTeT/S | India |
| 1998 | Shigella boydii | Fd | Russia |
| 2000 | Shigella flexneri | AmAugCTeT/S (2 isolates) | Pakistan, Mexico |
| 2000 | Shigella flexneri | AmAugCTe | Ivory Coast |
| 2000 | Shigella flexneri | TeT/S | India |
| 2000 | Shigella boydii | Te | India |
| 2000 | Shigella boydii | Susceptible | India |
*
Travel information was provided only for the province of Alberta. Am Ampicillin; Aug Amoxicillin/K clavulanate; C Chloramphenicol; Cax Ceftriaxone; Fd Nitrofurantoin; Pi Piperacillin; Te Tetracycline; T/S Trimethoprim/sulfamethoxazole